CombiMatrix (NASDAQ: CBMX ) has appointed a new CEO. Occupying that position will be Mark McDonough, currently the chief commercial officer of the firm. He replaces the retiring R. Judd Jessup, and will formally take up his new job on March 15.
McDonough is a veteran executive. He has held positions at Ventana Medical Systems (a subsidiary of Roche), and LabCorp (NYSE: LH ) , where he served as vice president of sales.
CombiMatrix quoted Jessup as saying of the CEO-to-be that:
We have now refocused the organization on key markets where we are seeing rapid growth and Mark has led that execution over the past eight months. I believe the Company is headed in the right direction, is building momentum and is in very capable hands.